In Treatment of Type 2 diabetes mellitus Sitara 50 Tablet belongs to a group of medicines called DPP-4 inhibitors (or gliptins). It works by helping to increase the amount of insulin your body produces after a meal and to stop your body from releasing too much glucose (sugar) into your blood. The effect is to lower blood glucose levels. This medicine is usually taken once a day, has relatively few common side effects, and does not usually make you put on weight. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Proper control of diabetes can also reduce the risk of heart disease and stroke. Taking this medicine regularly along with a proper program of diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
It is unsafe to consume alcohol with Sitara 50 Tablet.
Sitara 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Sitara 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Sitara 50 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Sitara 50 Tablet may be needed. Please consult your doctor.
Sitara 50 Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Sitara 50 Tablet may not be needed in these patients. Please consult your doctor. However, Sitara 50 Tablet has not been studied in patients with severe hepatic impairment and is not recommended for use in such patients.
If you miss a dose of Sitara 50 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: MSD Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nexina Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cadila Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wockhardt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glenmark Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Daksh Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Healthcare Limited || ₹14.5/tablet (25% cheaper)